Toceranib-d8 - CAS# 1795134-78-9 023moc-Val-Cit-PAB-MMAE 0-12 hours) induces autophagy of

0-12 hours) induces autophagy of SW480 cells

attenuates airway inflammation in a multi-allergen challenged mouse model

Chemical Name: 2-[(3S)-3-methylmorpholin-4-yl]-N-{[2-(trifluoromethyl)pyridin-3-yl]methyl}pyrido[2

7-dimethoxy-2-(2-phenylethyl)-4H-chromen-4-one

Toceranib-d8 - CAS# 1795134-78-9 023moc-Val-Cit-PAB-MMAE 0-12 hours) induces autophagy ofToceranib d8 is the deuterium labeled Toceranib. Toceranib (SU11654) is an orally active receptor tyrosine kinase (RTK) inhibitor, and it potently inhibits PDGFR, VEGFR, and Kit with Kis of 5 and 6 nM for PDGFR and Flk 1 KDR, respectively. Toceranib (SU11654) has antitumor and antiangiogenic activity, and used in the treatment of canine mast cell tumors. Product information CAS Number: 1795134 78 9 Molecular Weight: 404. 51 Formula: C22H25FN4O2